Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: Final analysis of a multicentre, open-label, early-access protocol trial

  1. Sternberg, C.N.
  2. Castellano, D.
  3. Daugaard, G.
  4. Géczi, L.
  5. Hotte, S.J.
  6. Mainwaring, P.N.
  7. Saad, F.
  8. Souza, C.
  9. Tay, M.H.
  10. Garrido, J.M.T.
  11. Galli, L.
  12. Londhe, A.
  13. De Porre, P.
  14. Goon, B.
  15. Lee, E.
  16. McGowan, T.
  17. Naini, V.
  18. Todd, M.B.
  19. Molina, A.
  20. George, D.J.
Revue:
The Lancet Oncology

ISSN: 1474-5488 1470-2045

Année de publication: 2014

Volumen: 15

Número: 11

Pages: 1263-1268

Type: Article

DOI: 10.1016/S1470-2045(14)70417-6 GOOGLE SCHOLAR